⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LPCN News
Lipocine Inc.
Form 8-K
sec.gov
LPCN
Form 8-K
sec.gov
LPCN
Form 8-K
sec.gov
LPCN
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
prnewswire.com
LPCN
Form 8-K
sec.gov
LPCN
Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting
prnewswire.com
LPCN
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer
globenewswire.com
LPCN
Form 8-K
sec.gov
LPCN
Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase
prnewswire.com
LPCN
Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
prnewswire.com
LPCN